Intel
INTC
Micron Technology
MU
Oracle
ORCL
Alibaba
BABA
Qualcomm
QCOM
US Stock MarketDetailed Quotes
ORTX Orchard Therapeutics
- 0.0000
- 0.00000.00%
Trading Feb 18 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)22.76MShares16.720052wk High0.00P/B0Float Cap16.585052wk Low--Dividend TTM11.73MShs Float216.4000Historical High--Div YieldTTM0.00%Amplitude3.6010Historical Low--Avg Price1Lot Size
Orchard Therapeutics Key Stats
EPS
According to the latest financial report of Orchard Therapeutics, the latest earnings per share (TTM) for the company is -1.50. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Orchard Therapeutics's free cash flow? The latest report shows it as -24.02M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Orchard Therapeutics shows that the company's current ratio is 3.12, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Orchard Therapeutics, the quick ratio is 2.88, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Orchard Therapeutics? The latest ROE figure is -37.31%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Orchard Therapeutics, the total asset return on investment (ROA) is -16.25%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Orchard Therapeutics's latest financial report to see how their gross margin is doing - currently at 72.31%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Orchard Therapeutics, the net profit margin is -560.44%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.